Variants in CLDN5 cause a syndrome characterized by seizures, microcephaly and brain calcifications.
CLDN5
blood–brain barrier
brain calcifications
Journal
Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537
Informations de publication
Date de publication:
01 06 2023
01 06 2023
Historique:
received:
28
06
2022
revised:
17
11
2022
accepted:
19
11
2022
medline:
2
6
2023
pubmed:
9
12
2022
entrez:
8
12
2022
Statut:
ppublish
Résumé
The blood-brain barrier ensures CNS homeostasis and protection from injury. Claudin-5 (CLDN5), an important component of tight junctions, is critical for the integrity of the blood-brain barrier. We have identified de novo heterozygous missense variants in CLDN5 in 15 unrelated patients who presented with a shared constellation of features including developmental delay, seizures (primarily infantile onset focal epilepsy), microcephaly and a recognizable pattern of pontine atrophy and brain calcifications. All variants clustered in one subregion/domain of the CLDN5 gene and the recurrent variants demonstrate genotype-phenotype correlations. We modelled both patient variants and loss of function alleles in the zebrafish to show that the variants analogous to those in patients probably result in a novel aberrant function in CLDN5. In total, human patient and zebrafish data provide parallel evidence that pathogenic sequence variants in CLDN5 cause a novel neurodevelopmental disorder involving disruption of the blood-brain barrier and impaired neuronal function.
Identifiants
pubmed: 36477332
pii: 6881740
doi: 10.1093/brain/awac461
doi:
Substances chimiques
Claudin-5
0
CLDN5 protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2285-2297Subventions
Organisme : Medical Research Council
ID : MC_UU_00006/2
Pays : United Kingdom
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.